Butyric Acid → HCID 178454567, compound

HRID 1260746Notes

Reaction equation

HRID 1260746 reaction equation
Cl.Cl.Cl.[O:4]1[C:8]2=[C:9]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH2:27])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[N:10]=[CH:11][CH:12]=[C:7]2[CH2:6][CH2:5]1.[C:28](O)(=[O:32])[CH2:29][CH2:30][CH3:31]>>[O:4]1[C:8]2=[C:9]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH:27][C:28](=[O:32])[CH2:29][CH2:30][CH3:31])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[N:10]=[CH:11][CH:12]=[C:7]2[CH2:6][CH2:5]1

Participants

3

Reactant 2

HCID 264Butyric AcidHCID 178478590HCID 178478590, compound2×

Product 1

HCID 178454567HCID 178454567, compound

Procedure

The title compound, white solid (91 mg, 91%), MS (ISP) m/z=401.5 [(M+H)+], mp 183° C., was prepared in accordance with the general method of example 6 from trans-4-{2-[4-(2,3-dihydro-furo[2,3-c]pyridin-7-yl)-piperazin-1-yl]-ethyl}-cyclohexylamine trihydrochloride (intermediate B) (110 mg, 0.25 mmol) and butyric acid.

Sources & evidence

ORD record
ord-1f4fc586341347b29d1269faefc3a808
Source dataset
uspto-grants-2013_06
Patent number
US08470828B2

Reaction notes

Loading…